Organoid-based evaluation of SA55 and Pemivibart against evolving SARS-CoV-2 variants

Wan et al., Emerging Microbes & Infections, doi:10.1080/22221751.2026.2713323, Aug 2026
In vitro study evaluating the neutralization of pemivibart and SA55 monoclonal antibodies against SARS-CoV-2 variants using human nasal organoids and conventional cell lines. Pemivibart lost ~60-80-fold potency against the current XFG and KP.3.1.1 subvariants, while SA55 neutralized all variants tested with IC50 ≤ 40 ng/mL and cut BA.5.2 and XFG replication by over 3 log units.
Efficacy is variant dependent. In Vitro research shows reduced efficacy against KP.3.1.1, KP.1.1, LB.1, KP.3.3, and XEC variants1-4.
3 preclinical studies support the efficacy of pemivibart for COVID-19:
3 in vitro studies5-7
Wan et al., 12 Aug 2026, China, peer-reviewed, 21 authors. Contact: jiezhou@hku.hk.
In vitro studies are an important part of preclinical research, however results may be very different in vivo.
Abstract: ta C Taylor & Francis + al C al C Latil A es C CrossMark Emerging Microbes & Infections ISSN: 2222-1751 (Online) Journal homepage: www.tandfonline.com/journals/temi20 Organoid-based evaluation of SA55 and Pemivibart against evolving SARS-CoV-2 variants Zhixin Wan, Ying Zhou, Fanchong Jian, Jiali Wu, Wei Xue , Man Chun Chiu, Yifei Yu, Qiaoshuai Lan, Shuxin Zhang , Zijun Zhao, Xiaoxin Zhu , Jingjing Huang , Yidong Yang, Yuhong Liu, Xinjie Meng, Lin Huang , Xiang Gao, Hin Chu, Cun Li, Yunlong Cao & Jie Zhou To cite this article: Zhixin Wan, Ying Zhou, Fanchong Jian, Jiali Wu, Wei Xue , Man Chun Chiu, Yifei Yu, Qiaoshuai Lan, Shuxin Zhang , Zijun Zhao, Xiaoxin Zhu , Jingjing Huang , Yidong Yang, Yuhong Liu, Xinjie Meng, Lin Huang , Xiang Gao, Hin Chu, Cun Li, Yunlong Cao & Jie Zhou (2026) Organoid-based evaluation of SA55 and Pemivibart against evolving SARS-CoV-2 variants, Emerging Microbes & Infections, 15:1, 2713323, DOI: 10.1080/22221751.2026.2713323 To link to this article: https://doi.org/10.1080/22221751.2026.2713323 © 2026 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd View supplementary material Published online: 12 Aug 2026. Submit your article to this journal Article views: 874 View related articles View Crossmark data EMERGING AND RE-EMERGING CORONAVIRUSES Organoid-based evaluation of SA55 and Pemivibart against evolving SARSCoV-2 variants ``` Zhixin Wan a # , Ying Zhou a,b # , Fanchong Jian c , Jiali Wu a , Wei Xue a , Man Chun Chiu a,b , Yifei Yu a,b , Qiaoshuai Lan a,b , Shuxin Zhang a , Zijun Zhao a , Xiaoxin Zhu a,b , Jingjing Huang a,b , Yidong Yang a , Yuhong Liu a,b , Xinjie Meng a , Lin Huang d , Xiang Gao e , Hin Chu a,b,f,g , Cun Li a , Yunlong Cao c and Jie Zhou a,b,d,f,g ``` a Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; b Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, People's Republic of China; c Biomedical Pioneering Innovation Center, School of Life Sciences, Peking University, Beijing, People's Republic of China; d BiomOrgan Ltd, Hong Kong, People's Republic of China; e Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, People's Republic of China; f State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; g Pandemic Research Alliance Unit at The University of Hong Kong, The University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China ABSTRACT Pemivibart, a class 1/4 monoclonal antibody (mAb), is currently the only FDA-authorized SARS-CoV-2 mAb under an Emergency Use Authorization (EUA) in clinical use. The emergence of subvariants, including KP.3.1.1 and XFG, raises concerns about antibody efficacy. SA55, a fully human class 1/4 mAb, is currently under clinical trial, including a nasal spray formulation. Using the well-validated organoid-based neutralization assays, we compared the potency and breadth of Pemivibart and SA55. Our results demonstrated a significant ..
DOI record: { "DOI": "10.1080/22221751.2026.2713323", "ISSN": [ "2222-1751" ], "URL": "http://dx.doi.org/10.1080/22221751.2026.2713323", "alternative-id": [ "10.1080/22221751.2026.2713323" ], "article-number": "2713323", "assertion": [ { "label": "Peer Review Statement", "name": "peerreview_statement", "order": 1, "value": "The publishing and review policy for this title is described in its Aims & Scope." }, { "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=temi20", "label": "Aim & Scope", "name": "aims_and_scope_url", "order": 2, "value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=temi20" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Received", "name": "received", "order": 0, "value": "2026-04-21" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Revised", "name": "revised", "order": 1, "value": "2026-06-28" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "2026-07-29" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Published", "name": "published", "order": 3, "value": "2026-08-12" } ], "author": [ { "ORCID": "https://orcid.org/0009-0005-4411-6659", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Wan", "given": "Zhixin", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "first" }, { "ORCID": "https://orcid.org/0000-0003-1443-8874", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Zhou", "given": "Ying", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-8703-3507", "affiliation": [ { "name": "Peking University", "place": [ "Beijing, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Jian", "given": "Fanchong", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-7935-3946", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Wu", "given": "Jiali", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "family": "Xue", "given": "Wei", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-9503-6396", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Chiu", "given": "Man Chun", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0009-0005-0236-3213", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Yu", "given": "Yifei", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-5524-3542", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Lan", "given": "Qiaoshuai", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "family": "Zhang", "given": "Shuxin", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0009-0008-6283-2343", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Zhao", "given": "Zijun", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "family": "Zhu", "given": "Xiaoxin", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "family": "Huang", "given": "Jingjing", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0009-0004-7696-3943", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Yang", "given": "Yidong", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-1469-271X", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Liu", "given": "Yuhong", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-6169-5729", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Meng", "given": "Xinjie", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "BiomOrgan Ltd", "place": [ "Hong Kong, People’s Republic of China" ] } ], "family": "Huang", "given": "Lin", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-1710-4204", "affiliation": [ { "name": "Beijing Institute of Biotechnology", "place": [ "Beijing, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Gao", "given": "Xiang", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-2855-9837", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Chu", "given": "Hin", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-3003-0000", "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Li", "given": "Cun", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-5918-1078", "affiliation": [ { "name": "Peking University", "place": [ "Beijing, People’s Republic of China" ] } ], "authenticated-orcid": false, "family": "Cao", "given": "Yunlong", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" }, { "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "Hong Kong Science and Technology Park", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "BiomOrgan Ltd", "place": [ "Hong Kong, People’s Republic of China" ] }, { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] }, { "name": "The University of Hong Kong", "place": [ "Hong Kong Special Administrative Region, People’s Republic of China" ] } ], "family": "Zhou", "given": "Jie", "role": [ { "role": "author", "vocabulary": "crossref" } ], "sequence": "additional" } ], "container-title": "Emerging Microbes & Infections", "container-title-short": "Emerging Microbes & Infections", "content-domain": { "crossmark-restriction": true, "domain": [ "www.tandfonline.com" ] }, "created": { "date-parts": [ [ 2026, 8, 3 ] ], "date-time": "2026-08-03T14:18:49Z", "timestamp": 1785766729000 }, "deposited": { "date-parts": [ [ 2026, 8, 12 ] ], "date-time": "2026-08-12T18:35:35Z", "timestamp": 1786559735000 }, "funder": [ { "DOI": "10.13039/501100018537", "award": [ "2025ZD01904200" ], "award-info": [ { "award-number": [ "2025ZD01904200" ] } ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100018537", "id-type": "DOI" } ], "name": "National Science and Technology Major Project" }, { "award": [ "CID-HKU1-3" ], "award-info": [ { "award-number": [ "CID-HKU1-3" ] } ], "name": "Control of Infectious Diseases" }, { "award": [ "COVID1903010-project 11" ], "award-info": [ { "award-number": [ "COVID1903010-project 11" ] } ], "name": "novel coronavirus disease" }, { "award": [ "2021YFC0866100" ], "award-info": [ { "award-number": [ "2021YFC0866100" ] } ], "name": "National Key R&D Program" }, { "DOI": "10.13039/501100008804", "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100008804", "id-type": "DOI" } ], "name": "Ministry of Science and Technology" }, { "award": [ "GRF" ], "award-info": [ { "award-number": [ "GRF" ] } ], "name": "General Research Fund" }, { "award": [ "17105420" ], "award-info": [ { "award-number": [ "17105420" ] } ], "name": "General Research Fund" }, { "award": [ "17113724" ], "award-info": [ { "award-number": [ "17113724" ] } ], "name": "General Research Fund" }, { "award": [ "CRF" ], "award-info": [ { "award-number": [ "CRF" ] } ], "name": "Collaborative Research Fund" }, { "award": [ "C7042-21G" ], "award-info": [ { "award-number": [ "C7042-21G" ] } ], "name": "Collaborative Research Fund" } ], "indexed": { "date-parts": [ [ 2026, 8, 12 ] ], "date-time": "2026-08-12T19:27:52Z", "timestamp": 1786562872089, "version": "build-2736575974" }, "is-referenced-by-count": 0, "issue": "1", "issued": { "date-parts": [ [ 2026, 8, 12 ] ] }, "journal-issue": { "issue": "1", "published-print": { "date-parts": [ [ 2026, 12, 31 ] ] } }, "language": "en", "license": [ { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2026, 8, 12 ] ], "date-time": "2026-08-12T00:00:00Z", "timestamp": 1786492800000 } }, { "URL": "https://doi.org/10.1080/policies-text-data-mining", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2026, 8, 12 ] ], "date-time": "2026-08-12T00:00:00Z", "timestamp": 1786492800000 } } ], "link": [ { "URL": "https://www.tandfonline.com/doi/pdf/10.1080/22221751.2026.2713323", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://www.tandfonline.com/doi/full-xml/10.1080/22221751.2026.2713323", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://www.tandfonline.com/doi/pdf/10.1080/22221751.2026.2713323", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "301", "original-title": [], "prefix": "10.1080", "published": { "date-parts": [ [ 2026, 8, 12 ] ] }, "published-online": { "date-parts": [ [ 2026, 8, 12 ] ] }, "published-print": { "date-parts": [ [ 2026, 12, 31 ] ] }, "publisher": "Informa UK Limited", "reference": [ { "DOI": "10.1001/jama.2024.18589", "doi-asserted-by": "publisher", "key": "e_1_3_4_2_1" }, { "DOI": "10.1016/S1473-3099(25)00308-1", "doi-asserted-by": "publisher", "key": "e_1_3_4_3_1" }, { "DOI": "10.1056/NEJMc2410203", "doi-asserted-by": "publisher", "key": "e_1_3_4_4_1" }, { "DOI": "10.20411/pai.v10i1.752", "doi-asserted-by": "publisher", "key": "e_1_3_4_5_1" }, { "article-title": "Neutralization of recent SARS-CoV-2 variants by genetically and structurally related mAbs of the pemivibart lineage", "author": "Powers C", "first-page": "2024.11.11.6231", "journal-title": "bioRxiv", "key": "e_1_3_4_6_1", "unstructured": "Powers C, Williams B, Kreher A, et al. Neutralization of recent SARS-CoV-2 variants by genetically and structurally related mAbs of the pemivibart lineage. bioRxiv. 2024:2024.11.11.623127.", "year": "2024" }, { "DOI": "10.1016/j.celrep.2022.111845", "doi-asserted-by": "publisher", "key": "e_1_3_4_7_1" }, { "DOI": "10.1016/j.chom.2022.09.018", "doi-asserted-by": "publisher", "key": "e_1_3_4_8_1" }, { "DOI": "10.3390/pharmaceutics17010043", "doi-asserted-by": "publisher", "key": "e_1_3_4_9_1" }, { "DOI": "10.1038/s41421-022-00422-1", "doi-asserted-by": "publisher", "key": "e_1_3_4_10_1" }, { "DOI": "10.1073/pnas.2300376120", "doi-asserted-by": "publisher", "key": "e_1_3_4_11_1" }, { "DOI": "10.1073/pnas.2509616122", "doi-asserted-by": "publisher", "key": "e_1_3_4_12_1" }, { "DOI": "10.1093/cid/ciaf265", "doi-asserted-by": "publisher", "key": "e_1_3_4_13_1" }, { "DOI": "10.1111/cts.70421", "doi-asserted-by": "publisher", "key": "e_1_3_4_14_1" }, { "article-title": "Antibody transcytosis and neutralizing activity in respiratory epithelial cells", "author": "Anaya EU", "first-page": "2026.05.25.7276", "journal-title": "bioRxiv", "key": "e_1_3_4_15_1", "unstructured": "Anaya EU, Vue Y, Li M, et al. Antibody transcytosis and neutralizing activity in respiratory epithelial cells. bioRxiv. 2026:2026.05.25.727697.", "year": "2026" }, { "DOI": "10.1038/s41586-020-2575-3", "doi-asserted-by": "publisher", "key": "e_1_3_4_16_1" } ], "reference-count": 15, "references-count": 15, "relation": {}, "resource": { "primary": { "URL": "https://www.tandfonline.com/doi/full/10.1080/22221751.2026.2713323" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Organoid-based evaluation of SA55 and Pemivibart against evolving SARS-CoV-2 variants", "type": "journal-article", "update-policy": "https://doi.org/10.1080/tandf_crossmark_01", "volume": "15" }